| Original language | English (US) |
|---|---|
| Pages (from-to) | 2537-2540 |
| Number of pages | 4 |
| Journal | Journal of Investigative Dermatology |
| Volume | 142 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 2022 |
ASJC Scopus subject areas
- Dermatology
- Molecular Biology
- Biochemistry
- Cell Biology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of Investigative Dermatology, Vol. 142, No. 9, 09.2022, p. 2537-2540.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Cutaneous Transcriptomics Identifies Fibroproliferative and Neurovascular Gene Dysregulation in Prurigo Nodularis Compared with Psoriasis and Atopic Dermatitis
AU - Sutaria, Nishadh
AU - Alphonse, Martin Prince
AU - Roh, Youkyung S.
AU - Choi, Justin
AU - Parthasarathy, Varsha
AU - Deng, Junwen
AU - Bordeaux, Zachary A.
AU - Taylor, Matthew T.
AU - Pritchard, Thomas
AU - Kim, Noori
AU - Aguh, Crystal
AU - Semenov, Yevgeniy R.
AU - Archer, Nathan K.
AU - Garza, Luis A.
AU - Kang, Sewon
AU - Kwatra, Shawn G.
N1 - Funding Information: SGK is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award number K23AR077073. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This study is approved by the Johns Hopkins Institutional Review Board (IRB00119007). Conceptualization: SGK, MPA, NS; Data Curation: NS; Formal Analysis: NS; Funding Acquisition: SGK; Investigation: MPA, NS; Methodology: MPA, NS; Project Administration: SGK, TP; Resources: SGK; Software: NS; Supervision: SGK, MPA; Validation: MPA; Visualization: NS; Writing - Original Draft Preparation: NS, MPA, YSR, JC, VP, JD, ZAB, MTT; Writing - Review and Editing: NS, MPA, YSR, JC, VP, JD, ZAB, MTT, TP, NK, CA, YRS, NKA, LAG, SK, SGK, SGK is an advisory board member/consultant for AbbVie, Celldex Therapeutics, Galderma, Incyte Corporation, Pfizer, Regeneron Pharmaceuticals, and Kiniksa Pharmaceuticals and has served as an investigator for Galderma, Kiniksa Pharmaceuticals, Pfizer, and Sanofi. NKA has received financial support from Pfizer. The remaining authors state no conflict of interest. Funding Information: SGK is an advisory board member/consultant for AbbVie, Celldex Therapeutics, Galderma, Incyte Corporation, Pfizer, Regeneron Pharmaceuticals, and Kiniksa Pharmaceuticals and has served as an investigator for Galderma, Kiniksa Pharmaceuticals, Pfizer, and Sanofi. NKA has received financial support from Pfizer. The remaining authors state no conflict of interest. Funding Information: SGK is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award number K23AR077073 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This study is approved by the Johns Hopkins Institutional Review Board (IRB00119007).
PY - 2022/9
Y1 - 2022/9
UR - http://www.scopus.com/inward/record.url?scp=85127316362&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127316362&partnerID=8YFLogxK
U2 - 10.1016/j.jid.2022.02.010
DO - 10.1016/j.jid.2022.02.010
M3 - Article
C2 - 35257721
AN - SCOPUS:85127316362
SN - 0022-202X
VL - 142
SP - 2537
EP - 2540
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
IS - 9
ER -